Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of Revumenib and Mezigdomide in People With Leukemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of Revumenib and Mezigdomide for various forms of leukemia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating venetoclax in combination with the CACAG regimen for newly diagnosed acute myeloid leukemia has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Music Therapy in Acute Leukemia Patients With Fatigue [NA]
A completed clinical trial evaluating music therapy for fatigue in patients with acute myeloid leukemia; results have been posted.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
A clinical trial update describing a study to identify barriers to allogeneic hematopoietic stem cell transplantation in patients with newly…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms. [Phase 1]
A Phase 1 clinical trial of BYON4413 in relapsed/refractory acute myeloid leukemia and myelodysplastic neoplasms reports safety, pharmacokin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant [Phase 1]
Phase 1 trial of ONC-201 as maintenance therapy after stem cell transplant in acute myeloid leukemia and myelodysplastic syndromes has compl…
-
EMA approval · 2026-01-16EMA Authorised: Xospata (gilteritinib fumarate) — Astellas Pharma Europe B.V.
The EMA authorised Xospata (gilteritinib fumarate) for acute myeloid leukemia; the marketing authorization holder is Astellas Pharma Europe …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Phase 1]
Clinical trial update indicates CLN-049 is being studied for relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome in a Ph…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: CART123 + Ruxolitinib in Relapsed/Refractory AML [Phase 1]
A Phase 1 trial is evaluating CART123 CAR T therapy in combination with ruxolitinib for relapsed or refractory acute myeloid leukemia; the s…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML [Phase 1]
A Phase 1 clinical trial is evaluating venetoclax in combination with intensive induction and consolidation chemotherapy in treatment-naïve …
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
The Orca-T Expanded Access Program study for patients with advanced hematologic malignancies has a status update. The study is temporarily n…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 trial evaluating Velcade (bortezomib) and lenalidomide in patients with relapsed myelodysplastic syndrome or acute myeloid leukemi…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies [Phase 1]
A Phase 1 study evaluating CG009301 for injection in adults with recurrent or refractory hematologic malignancies; recruitment is ongoing fo…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
This document describes the REVIVE study, a clinical trial evaluating the safety and effectiveness of venetoclax in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS [Phase 1]
Phase 1 clinical trial of CD64 CAR T cell therapy for adults with relapsed/refractory AML or high-risk MDS. The trial status is not yet recr…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Removing Transfusion Dependence as a Barrier to Hospice Enrollment [NA]
A completed clinical trial update indicates that transfusion dependence was removed as a barrier to hospice enrollment for patients with hem…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating mitoxantrone for venetoclax-resistant acute myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .
A study protocol to assess clinico-hematological and coagulation profiles in newly diagnosed acute myeloid leukemia patients treated with in…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia [NA]
This clinical trial update describes a planned study of CLL-1–targeted CAR-T therapy followed by allogeneic hematopoietic stem cell transpla…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: CC-486 and Venetoclax for Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial evaluating CC-486 (oral azacitidine) in combination with venetoclax for acute myeloid leukemia, currently recruiting.
-
EMA approval · 2026-01-14EMA Authorised: Rydapt (Midostaurin) — Novartis Europharm Ltd
The European Medicines Agency authorised Rydapt (midostaurin) for additional indications in acute myeloid leukemia and systemic mastocytosis…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 clinical trial evaluating base-edited CAR T cells in relapsed acute myeloid leukemia, with deep conditioning ahead of allogeneic ste…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission [Phase 1]
Phase 1 maintenance therapy trial evaluating decitabine alone or with venetoclax, gilteritinib, enasidenib, or ivosidenib in AML in remissio…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients [NA]
This clinical trial update covers an extension study, pilot, and compassionate-use program for azacitidine 300 mg film-coated tablets in pat…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) [Phase 3]
A Phase 3 clinical trial update for Venetoclax in children with relapsed acute myeloid leukemia, with recruitment ongoing.